European drug agency recommends first combined COVID-19 and flu vaccine

The European Medicines Agency has recommended approval for the first combined vaccine protecting against both COVID-19 and influenza. The agency issued a conditional marketing authorization recommendation for the mCombriax vaccine, which would allow patients to receive protection against both viruses in a single shot. Slovakia's Ministry of Health acknowledged the agency's recommendation and is taking it under consideration. The European Commission, the EU's executive arm, holds final authority over vaccine registration and will make the ultimate decision on whether to approve the combined vaccine for use across the European Union.